Back

TransMedics names Fernando Araujo CFO, reiterates 2026 revenue guidance

Verifying
  • TransMedics appointed Fernando Araujo Chief Financial Officer effective September 21, 2026.
  • TransMedics reiterated 2026 revenue guidance of $737 million to $757 million.
  • Gerardo Hernandez will become Commercial Strategic Advisor, LATAM, leading Latin American expansion.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.